← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 15, 2019Last known activity
May 20, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (17 distinct, 11 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Studied for
Recent trials (23)
- NCT06968507Lead sponsorPhase 4May 20, 2025
- NCT06968507Sponsor investigatorPhase 4May 20, 2025
- NCT06968507OfficialPhase 4May 20, 2025
- NCT07307625Lead sponsorN/ADec 15, 2024
- NCT07307625Sponsor investigatorN/ADec 15, 2024
- NCT07248917Lead sponsorN/AOct 1, 2024
- NCT07248917Sponsor investigatorN/AOct 1, 2024
- NCT07288697Sponsor investigatorN/ANov 1, 2023
- NCT07288697Lead sponsorN/ANov 1, 2023
- NCT06040853Reponsible party - principal investigatorPhase 4Sep 30, 2023
- NCT06040853Lead sponsorPhase 4Sep 30, 2023
- NCT06040853Sponsor investigatorPhase 4Sep 30, 2023
- NCT05668286Lead sponsorN/AJan 24, 2023
- NCT05668286Reponsible party - principal investigatorN/AJan 24, 2023
- NCT04750967Reponsible party - principal investigatorN/AApr 3, 2021
Details
- Last known activity
- May 20, 2025